DUBLIN--(BUSINESS WIRE)--The "2018 Global Chancroid Diagnostics Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers" report has been added to ResearchAndMarkets.com's offering.
The report presents a detailed analysis of the Chancroid diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chancroid definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Chancroid tests.
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Companies Featured
- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Biotest
- Cepheid
- Decode Genetics
- Diadexus
- Diamedix
For more information about this report visit https://www.researchandmarkets.com/research/pd32rr/global_chancroid?w=4
